** LeMaitre Vascular's LMAT.O shares down 8.5% to $92.10, hit lowest since Oct 31 early Mon, as medical device co looks to raise capital
** Burlington, Massachusetts-based implants provider offering privately $150 mln convertible bonds (CBs) due Feb 2030
** It plans to use net proceeds, including purchase of additional notes, for general purposes, including potential acquisitions or investments in complementary companies, products, or technologies
** Co had ~$2.3 bln market cap as of Fri, per LSEG
** Despite move on the session, stock up ~63% YTD. Shares hit record intraday high of $109.58 three weeks ago
** Of 10 analysts covering LMAT, 7 rate "strong buy" or "buy", rest "hold" with $100 median PT - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380 ))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。